Top Markets
#1 GALA GALA +32.47%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.50%
#3 Bitcoin Cash Bitcoin Cash +31.11%
#4 Fabric Protocol Fabric Protocol +30.87%
#5 Tutorial Tutorial +30.85%
#6 Zora Zora +24.99%
#7 Talus Network Talus Network +24.40%
#8 Arowana Arowana +22.89%
#9 Useless Coin Useless Coin +22.84%
#10 aPriori aPriori +22.63%
Coin of the day
GALA GALA
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Kedudukan dalam Saham #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Harga Saham
$1.48
Disegerakkan terakhir: 2025-03-24
Modal Pasaran
$59.05M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Achilles Therapeutics plc (ACHL)

Kategori

Healthcare
Pendapatan untuk Achilles Therapeutics plc (ACHL)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Achilles Therapeutics plc, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Achilles Therapeutics plc dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH